Intramural Research at NCATS

The NIH intramural research program has shifted all
non-mission-critical laboratory operations to a maintenance phase in order to promote physical distancing and diminished transmission risk of
COVID-19. Effective Monday, March 23, 2020, only mission-critical functions within NIH research laboratories will be supported.

Experts in NCATS’ Division of Preclinical Innovation (DPI) develop system approaches that improve the efficiency and effectiveness of the translation process. Examples include advancing new technologies to make preclinical research more predictive and efficient or de-risking potential drug targets or research projects to make them more attractive for commercial investment.

Scientists in the division of preclinical innovation lab

 

NCATS intramural scientists have a scientific and operational freedom not bound by one system, disease or condition. Working within a flexible and productive environment, our scientific team can leverage state-of-the-art laboratories and collaborative relationships among government, industry, academia, and patient and rare disease communities to develop and test more robust translational science systems.

Resources Available to Scientific Collaborators

NCATS intramural scientists and staff have expertise across the entire preclinical translational space, including:

NCATS’ state-of-the-art laboratories, centralized in one location, offer a broad array of capabilities, such as:

NCATS robot

With this combination of a highly skilled translational science workforce, state-of-the-art facilities and informatics capabilities, and a strong commitment to team science and innovative partnerships, NCATS can help its research partners accelerate science, maximize efficiency and conserve limited resources. Learn more about how to collaborate with NCATS’ intramural team.

Division of Preclinical Innovation Staff

Contact the staff listed below for more information about the NCATS Division of Preclinical Innovation: